Market Overview

Jim Cramer Advises His Viewers On Array Biopharma, GoPro & Sprint Corp

Related ARRY
Stocks Hitting 52-Week Highs
Watch These 7 Huge Call Purchases In Monday Trade
Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win (Investor's Business Daily)
Related GPRO
Wonderful Wearables Get Their Own ETF
Worst Performing Industries For December 8, 2016
The Vetr community has upgraded $GPRO to 4.5-Stars. (Vetr)

On CNBC's Mad Money, Jim Cramer said that Array Biopharma Inc (NASDAQ: ARRY) is a very speculative stock and he would own something less speculative in the current market environment.

Cramer thinks that GoPro Inc (NASDAQ: GPRO) was really good when it had a tight flow, but now he just wants to move onto a different trade.

Sprint Corp (NYSE: S) won't move much higher in the near term, he said, because the government hasn't allowed a merger with T-Mobile US Inc (NYSE: TMUS).

Posted-In: Jim Cramer Mad MoneyCNBC Media


Related Articles (ARRY + GPRO)

View Comments and Join the Discussion!